SCHEMBL14855596

SCHEMBL14855596

[CH2]c1ccc(C(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.76
LMNA P02545 2/20 0.76
SRD5A2 P31213 2/20 0.64
CES2 O00748 3/20 0.54
CES1 P23141 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.52
AKR1C3 P42330 1/20 0.48
HTT P42858 3/20 0.48
PKM P14618 2/20 0.48
ATM Q13315 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
HPGD P15428 1/20 0.48
NLRP1 Q9C000 1/20 0.48
GAA P10253 1/20 0.48
MEN1 O00255 1/20 0.48
NTSR1 P30989 1/20 0.48
KMT2A Q03164 1/20 0.48
RAB9A P51151 1/20 0.47
HDAC1 Q13547 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL822185 0.87 ALDH1A1 (1.00) ALDH1A1LMNASRD5A2CES2CES1
SCHEMBL9615865 0.87 SRD5A2 (0.55) ALDH1A1LMNASRD5A2HTTPKM
SCHEMBL52200 0.87 ALDH1A1 (1.00) ALDH1A1LMNASRD5A2CES2CES1
SCHEMBL11528213 0.85 ALDH1A1 (0.94) ALDH1A1LMNASRD5A2CES2CES1
Hydrochloric Acid SCHEMBL27909743 0.85 ALDH1A1 (0.94) ALDH1A1LMNASRD5A2CES2CES1
SCHEMBL19651362 0.80 ALDH1A1 (0.84) ALDH1A1LMNASRD5A2CES2CES1
SCHEMBL12362778 0.80 ALDH1A1 (0.84) ALDH1A1LMNASRD5A2CES2CES1
SCHEMBL13356677 0.80 ALDH1A1 (0.84) ALDH1A1LMNASRD5A2CES2CES1
SCHEMBL6454990 0.80 ALDH1A1 (0.84) ALDH1A1LMNASRD5A2CES2CES1
SCHEMBL19651365 0.80 ALDH1A1 (0.84) ALDH1A1LMNASRD5A2CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130165446-A1 BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE HORIKOSHI, HIROYOSHI (CA) 2013-06-27 US claimed
EP-2581373-A1 BENZO- OR PYRIDO-IMIDAZOLE DERIVATIVE Fujita, Takashi (JP) 2013-04-17 EP claimed
US-20130165446-A1 BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE HORIKOSHI, HIROYOSHI (CA) 2013-06-27 US disclosed
EP-2581373-A1 BENZO- OR PYRIDO-IMIDAZOLE DERIVATIVE Fujita, Takashi (JP) 2013-04-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165446-A1 BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE PPARG, PPARA, PPARD ALDH1A1 1612/4885LMNA 3164/4885SRD5A2 1550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.